are alternatives to remaining an in-patient for surgery on an emergency list. For example, these patients can be discharged home once their symptoms have settled, with a date for a laparoscopic cholecystectomy within a month, on a dedicated (potentially day-case) 'hot gallbladder' list.
The authors must be commended on their elaborate effort to prove the futility of D-dimer testing in postoperative patients. Innumerable studies have been done to try and prove the usefulness of D-dimer testing along with pre-test probability score, all aimed at avoiding expensive imaging. [1] [2] [3] The study could have been more meaningful if they had clarified the following issues:
1. The specificity and sensitivity of D-dimer levels vary with the type of test-enzyme-linked immunofluorescence assay (ELFA), microplate enzyme-linked immunosorbent assay (ELISA) or latex quantitative assay; the authors have not mentioned which test type did they use. 4 2. In the historical controls, only 37% patients had deep vein thrombosis (DVT) on or before day 7 after joint replacement surgery. The assessment of D-dimers preoperatively and on postoperative days 1, 3, 5, 7 and duplex imaging on day 7 would have missed out a major proportion of patients likely to develop DVT (up to 63%). Considering the fact that the authors first presented this work in 2005, follow-up data on these 78 patients, if available, could have made the present publication more meaningful.
3. The value of day 1 D-dimer in the published abstracts 5, 6 of their presentations is 3.63 compared to 3.39 in the present article, without any obvious change in any other numbers, probably a typing error in the present article. D-Dimer should remain as a screening test for proximal DVT and pulmonary embolism for out-patients with low clinical probability of DVT, where it obviates the need for a duplex ultrasound examination. Positive D-dimer, irrespective of its value, has little meaning when the probability of clinical DVT is high.
